Between January 23 and January 26, the Rolex 24 will kick off the start of the 2025 racing season down at Daytona ... and both can compete in either WEC or IMSA. Le Mans Daytona h (LMDh): LMDh ...
Samantha Tan made a successful start to her maiden VP Racing SportsCar Challenge campaign, with back-to-back class podiums on the series’ opening weekend at Daytona. On her first run as part of an ...
that he will wear in the Michelin Pilot Challenge race on Friday. The married couple are one of eight different teams that have family members racing together in Friday’s four-hour endurance race. (AP ...
We advise you to avoid simply saving the image previews you see below. These wallpaper previews are compressed and optimized for improved website performance. Instead, you should click the button ...
IndyCar legend Scott Dixon will run another Rolex 24 at Daytona this week. So will 2022 Daytona 500 winner Austin Cindric and NASCAR Cup Series rookie Shane van Gisbergen. Felipe Nasr, Dane ...
An axed Formula 1 star has issued an official statement ahead of their stunning racing return in 2025 ... and will compete in the IMSA SportsCar Championship. The Dane returned to the track in a test ...
The first 60 minutes and last two hours will air on NBC. USA, IMSA.TV and YouTube will share the middle portions. After that, IMSA, NASCAR’s sports-car cousin, will hibernate for six weeks.
Earl Bamber, who will compete in a Cadillac V-Series.R at the Rolex for Whelan Racing, is one of three drivers who will compete in both IMSA and the World Endurance Championship this year.
The Roar Before the Rolex 24 weekend at Daytona not only featured the opening rounds of the IMSA VP Racing Sportscar Challenge, but also the RAFA Racing Team’s IMSA Michelin Pilot Challenge ...
Stepping up in rainy conditions in Sunday’s second and final 45-minute sprint of the season-opening VP Racing Challenge doubleheader, Washington’s victory was his first in IMSA-sanctioned ...
The IMSA schedule offers an array of long days. Ten-hour race? Challenging. Twelve-hour race? Demanding. Twenty-four-hour race? A whole different ballgame. “Full transparency, this is the ...
IMSA-101 is under clinical development by ImmuneSensor Therapeutics and currently in Phase II for Hematological Tumor. According to GlobalData, Phase II drugs for Hematological Tumor does not have ...